Literature DB >> 12867410

Childhood ocular myasthenia gravis.

Jong-Hyun Kim1, Jeong-Min Hwang, Yong Seung Hwang, Ki Joong Kim, Jonghee Chae.   

Abstract

PURPOSE: To investigate the clinical manifestations and ocular findings in children with ocular myasthenia gravis (MG) that rarely have been reported in the literature.
DESIGN: Retrospective, noncomparative case series. PARTICIPANTS: Twenty-four consecutive patients less than 15 years of age with ocular MG treated between June 1988 and July 2001.
METHODS: The medical records of 6 boys and 18 girls with ocular MG were reviewed retrospectively. MAIN OUTCOME MEASURES: Alternate prism cover and uncover test, examination of ductions and versions, and visual acuity.
RESULTS: Mean age at onset was 38 months. Ptosis was found in 23 patients (96%), strabismus in 21 patients (88%), and amblyopia in 5 patients (21%). Exotropia combined with vertical heterotropia was the most frequent type of strabismus. Ductions were limited in 17 patients (71%), among whom supraduction or infraduction limitations were most frequently observed. Contrary to previous reports, medial rectus underaction was less common than lateral rectus underaction. Manifestations of strabismus and limitation of duction were variable and changed frequently during the follow-up period. The combined use of prednisone and pyridostigmine was found to be the predominant form of maintenance therapy, and ptosis was more responsive to drug therapy than limited ocular motility.
CONCLUSIONS: Children with ocular MG were found to have a high incidence of ptosis (96%) and exotropia and vertical hyperdeviation. Limitation on adduction was less common than that on abduction. First reported incidence of amblyopia (21%) and a relative nonresponsiveness of the limitation of eye movement to treatment were also noted.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12867410     DOI: 10.1016/S0161-6420(03)00460-3

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  9 in total

1.  Strabismus surgery and long-term visual outcomes in patients with preadolescent onset ocular myasthenia gravis.

Authors:  Jinu Han; So Young Han; Sueng-Han Han; Jong Bok Lee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-11-16       Impact factor: 3.117

2.  Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment.

Authors:  M J Kupersmith; G Ying
Journal:  Br J Ophthalmol       Date:  2005-10       Impact factor: 4.638

3.  Treatment for diplopia in patients with myasthenia gravis.

Authors:  Kyung-Ah Park; Sei Yeul Oh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-12-30       Impact factor: 3.117

4.  Initial Treatment Response in Ocular Myasthenia Gravis: A Comparison Between Low and Moderate Doses of Prednisolone.

Authors:  Thanatporn Threetong; Anuchit Poonyathalang; Pisit Preechawat; Panitha Jindahra; Tanyatuth Padungkiatsagul; Kavin Vanikieti
Journal:  Clin Ophthalmol       Date:  2020-07-22

5.  Ophthalmologic manifestations in myasthenia gravis: presentation and prognosis.

Authors:  Onur Akan; Leyla Baysal-Kirac
Journal:  Acta Neurol Belg       Date:  2021-01-04       Impact factor: 2.396

6.  Ocular Myasthenia Gravis.

Authors:  Neil C Porter; Brian C Salter
Journal:  Curr Treat Options Neurol       Date:  2005-01       Impact factor: 3.972

7.  Juvenile myasthenia gravis: a paediatric perspective.

Authors:  Maria F Finnis; Sandeep Jayawant
Journal:  Autoimmune Dis       Date:  2011-11-01

8.  Efficacy of Gaze Photographs in Diagnosing Ocular Myasthenia Gravis.

Authors:  Jeeyun Ahn; Kyung Seok Park; Ji Soo Kim; Jeong Min Hwang
Journal:  J Clin Neurol       Date:  2018-05-31       Impact factor: 3.077

Review 9.  The Epidemiology and Phenotypes of Ocular Manifestations in Childhood and Juvenile Myasthenia Gravis: A Review.

Authors:  Jeannine M Heckmann; Tarin A Europa; Aayesha J Soni; Melissa Nel
Journal:  Front Neurol       Date:  2022-02-23       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.